Stephen V Liu: Surgical Outcomes from AEGEAN Are Published in the Journal of Thoracic Oncology
Stephen V Liu, Director of Thoracic Oncology and Associate Professor of Medicine at Georgetown University, shared a post on X about a paper by Tetsuya Mitsudomi et al. published in the Journal of Thoracic Oncology:
“Surgical outcomes from AEGEAN (neoadjuvant durvalumab + chemo for NSCLC) now in the Journal of Thoracic Oncology from Tetsuya Mitsudomi. Same rate of surgery for both arms (81%) with higher R0 resection rates with durvalumab (95% vs 91%) and no diff in time to adjuvant treatment.”
Title: Surgical Outcomes with Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC
Authors: Tetsuya Mitsudomi, John V. Heymach, Martin Reck, Janis M. Taube, Shugeng Gao, Yoshitsugu Horio, Jian You, Gaofeng Li, Dinh Van Luong, Somcharoen Saeteng, Fumihiro Tanaka, Stefan B. Watzka, Laszlo Urban, Zsuzsanna Szalai, Hiroaki Akamatsu, Jin Hyoung Kang, Francisco J. Orlandi, Guzel Z. Mukhametshina, Andreas Pircher, Carlos Henrique Andrade Teixeira, Mike Aperghis, Gary J. Doherty, Ruth Doake, Tamer M. Fouad, David Harpole.
You can read the Full Article in the Journal of Thoracic Oncology.
More posts featuring Stephen V Liu.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023